What Multiple Myeloma With t(11;14) Should Be Classified Into in Novel Agent Era: Standard or Intermediate Risk?
Gao W, Du J, Liu J, Zhou H, Zhang Z, Jian Y, Yang G, Wang G, Tian Y, Li Y, Wu Y, Fu W, Li J, Chen W.
Gao W, et al. Among authors: zhou h.
Front Oncol. 2020 Oct 26;10:538126. doi: 10.3389/fonc.2020.538126. eCollection 2020.
Front Oncol. 2020.
PMID: 33194599
Free PMC article.